Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets
ABSTRACTTo exploit highly conserved and difficult drug targets, including multipass membrane proteins, monoclonal antibody discovery efforts increasingly rely on the advantages offered by divergent species such as rabbits, camelids, and chickens. Here, we provide an overview of antibody discovery te...
Saved in:
Main Authors: | Soma S.R. Banik (Author), Natasha Kushnir (Author), Benjamin J. Doranz (Author), Ross Chambers (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
VERITAS: Harnessing the power of nomenclature in biologic discovery
by: Riti Biswas, et al.
Published: (2023) -
Harnessing the cyclization strategy for new drug discovery
by: Kai Tang, et al.
Published: (2022) -
Harnessing bioluminescence for drug discovery and epigenetic research
by: Hannah J. Gleneadie, et al.
Published: (2023) -
Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness
by: Dominik Brücher, et al.
Published: (2020) -
The emergence of cell-based protein arrays to test for polyspecific off-target binding of antibody therapeutics
by: Diana M. Norden, et al.
Published: (2024)